A bill that would add revisions to cosmetics regulations has received bipartisan support. If approved, the bill would further the FDA’s ability to force companies to recall products and disclose information about public health risks.
The bill, co-sponsored by Sen. Dianne Feinstein (D-Calif.) and Sen. Susan Collins (R-Maine), would be the first major revision to industry regulations since 1938, The New York Times reports. It would give the FDA the power to force recalls and disclose “serious” health effects, such as disfigurement and death, within 15 business days. Under current regulations, cosmetics companies voluntarily recall products and disclose health information.
The bill would also allow the FDA to study five cosmetic chemicals a year. The first set includes propylparaben, which is used to preserve many cosmetics, and lead acetate, which is common in men’s hair dye. Meghan DeMaria